Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum | ||
By: GlobeNewswire - 08 Mar 2024 | Back to overview list |
|
CARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum, which takes place virtually March 19-20, 2024. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Exagen’s Chief Financial Officer, will participate in one-on-one meetings with investors and a fireside chat on Wednesday, March 20, at 1:30 PM ET. About Exagen Inc. For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter). Contact:
|
||
|
||
Copyright 2024 GlobeNewswire | Back to overview list |